digital health vendors glp-1 medication-assisted weight loss programs Virtual startups: Pill mills or the future of obesity care? Found Health Launches GLP-1 Microdosing
Description
The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...
Multiple devices can be grouped for live control of intensity, strobe and pulse effects, background and foreground colors, a variety of dynamic patterns and sound-to-light
Simple Use Within Daily Routines
GLP-1 (glucagon-like peptide-1) medications have emerged as a groundbreaking class of drugs, primarily used in the treatment of type 2 diabetes
The text also addresses the availability of GLP-1 medications and potential supply chain issues and encourages staying informed about market trends and available support services
Weight loss efficacy was also assessed in DIO mice.
